2024
Longitudinal associations of microstructural changes, amyloid, and cognition in preclinical Alzheimer's disease
Vannini P, Bertazzoli G, Rodriguez‐Vieitez E, Ramseyer M, Diez I, Sepulcre J, Hanseeuw B, Lois C, Gagliardi G, Westin C, Johnson K, Sperling R, Marshall G. Longitudinal associations of microstructural changes, amyloid, and cognition in preclinical Alzheimer's disease. Alzheimer's & Dementia 2024, 20: e089927. PMCID: PMC11714664, DOI: 10.1002/alz.089927.Peer-Reviewed Original ResearchCortical mean diffusivityCognitive declineLongitudinal associationsCortical thicknessHarvard Aging Brain StudyBaseline cortical thicknessCN older adultsAging Brain StudyCompound B PETLongitudinal cognitive declinePreclinical Alzheimer's diseaseDrug-induced changesCognitive covariatesIsthmus cingulateStructural MRIPost-hoc stratifying analysisCognitive AssessmentAt-risk individualsCognitionGeneralized linear modelBrain studiesMean diffusivityOlder adultsGray matterDiffusion-weighted imaging
2013
Methamphetamine-induced increases in putamen gray matter associate with inhibitory control
Groman SM, Morales AM, Lee B, London ED, Jentsch JD. Methamphetamine-induced increases in putamen gray matter associate with inhibitory control. Psychopharmacology 2013, 229: 527-538. PMID: 23748383, PMCID: PMC3770792, DOI: 10.1007/s00213-013-3159-9.Peer-Reviewed Original ResearchMeSH KeywordsAmphetamine-Related DisordersAnimalsChlorocebus aethiopsCognitionDiscrimination, PsychologicalDose-Response Relationship, DrugInhibition, PsychologicalMagnetic Resonance ImagingMaleMethamphetaminePositron-Emission TomographyPutamenReceptors, Dopamine D2Retention, PsychologyReversal LearningTime FactorsConceptsD2-like receptorsGray matterDrug usePositron emission tomography scanDopamine D2-like receptorsDrug-experienced individualsHuman methamphetamine usersRegimen of methamphetamineEmission tomography scanGray matter abnormalitiesMethamphetamine-induced increasesDrug-induced changesInhibitory controlNeurobiological risk factorsDopaminergic markersRisk factorsTomography scanDAT availabilityRight putamenTransporter availabilityPharmacological effectsStructural abnormalitiesRegimenMagnetic resonance imagesObjectivesThe purpose
2011
Noninvasive cardiac output monitoring with bioreactance as an alternative to invasive instrumentation for preclinical drug evaluation in beagles
Heerdt PM, Wagner CL, DeMais M, Savarese JJ. Noninvasive cardiac output monitoring with bioreactance as an alternative to invasive instrumentation for preclinical drug evaluation in beagles. Journal Of Pharmacological And Toxicological Methods 2011, 64: 111-118. PMID: 21440649, DOI: 10.1016/j.vascn.2011.03.006.Peer-Reviewed Original ResearchConceptsCardiac outputAortic blood flowDrug-induced changesBlood flowAcute drug-induced changesNoninvasive cardiac output monitoringNon-invasive measurementOpen-chest beaglesNeuromuscular blocking drugsPreclinical drug evaluationCardiac output monitoringDrug evaluation studiesML/minSimultaneous CO measurementsBlocking drugsAcute alterationsAortic rootPreclinical screeningChest instrumentationNICOMCO measurementsOutput monitoringDrug evaluationInvasive measurementsInvasive instrumentation
1990
Modulation of rat cortical area 17 neuronal responses to moving visual stimuli during norepinephrine and serotonin microiontophoresis
Waterhouse B, Azizi S, Burne R, Woodward D. Modulation of rat cortical area 17 neuronal responses to moving visual stimuli during norepinephrine and serotonin microiontophoresis. Brain Research 1990, 514: 276-292. PMID: 2357542, DOI: 10.1016/0006-8993(90)91422-d.Peer-Reviewed Original ResearchConceptsLong-Evans pigmented ratsSerotonin (5-HTReceptive field boundariesStimulus-evoked excitationPresentation of moving visual stimuliPeri-event histogramsAfferent synaptic inputApplication of NEDrug-induced changesAction of norepinephrineEffect of NEVisual stimuliRat cortical areasReceptive field bordersPigmented ratsSpontaneous dischargeSynaptic inputsStimulus-evokedEvoked responsesNE applicationCell activationNorepinephrineNeuronal responsesComparison to control conditionsAfferent signals
1989
The Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale: II. Validity. JAMA Psychiatry 1989, 46: 1012-1016. PMID: 2510699, DOI: 10.1001/archpsyc.1989.01810110054008.Peer-Reviewed Original ResearchConceptsObsessive-compulsive disorderYale-Brown Obsessive Compulsive ScaleObsessive Compulsive ScaleYale-Brown scaleScale scoreCompulsive ScaleSecondary depressive symptomsPlacebo-controlled trialCohort of patientsDrug-induced changesObsessive-compulsive disorder symptom severityMeasures of depressionDrug trialsOutcome measuresDisorder symptom severityDepressive symptomsObsessive-compulsive disorder symptomsSymptom severityPatientsBaseline ratingsDisordersDisorder symptomsValid instrumentSymptomsTrials
1986
The Effect of Drugs on Bile Flow and Composition
Okolicsanyi L, Lirussi F, Strazzabosco M, Jemmolo R, Orlando R, Nassuato G, Muraca M, Crepaldi G. The Effect of Drugs on Bile Flow and Composition. Drugs 1986, 31: 430-448. PMID: 2872047, DOI: 10.2165/00003495-198631050-00003.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsBileBile Acids and SaltsCatsChlorpromazineCholagogues and CholereticsCholesterolClofibrateColchicineCricetinaeDehydrocholic AcidDiureticsDogsEnterohepatic CirculationEstrogensGlucagonGuinea PigsHumansInsulinLiverMacaca mulattaPhospholipidsRabbitsRatsRifampinRifamycinsSomatostatinTheophyllineUrsodeoxycholic AcidConceptsBile flowBile acidsBile acid sequestrant cholestyramineBiliary bile acid secretionBiliary cholesterol concentrationBiliary cholesterol saturationBiliary cholesterol secretionBile acid concentrationsBile acid secretionBiliary phospholipid concentrationDrug-induced changesComposition of bileUnconjugated bile acidsEffects of drugsVariety of drugsCholesterol secretionHepatic secretionDrug therapyCholesterol saturationUrsodeoxycholic acidBiliary lipidsAcid secretionCholesterol concentrationsD-thyroxineHepatobiliary route
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply